PubMed:11133022
Annnotations
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 0-22 | Glycan_Motif | denotes | Globotriaosyl ceramide | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T2 | 162-184 | Glycan_Motif | denotes | globotriaosyl ceramide | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T3 | 186-189 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T4 | 354-357 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T5 | 489-492 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T6 | 704-707 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T7 | 889-892 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T8 | 1050-1053 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T9 | 1155-1158 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T10 | 1396-1399 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T11 | 1502-1505 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
| T12 | 1623-1626 | Glycan_Motif | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00059MO |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-124 | Sentence | denotes | Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells. |
| TextSentencer_T2 | 125-337 | Sentence | denotes | Previous studies have indicated that globotriaosyl ceramide (Gb3 or CD77) plays a role in alpha-interferon signal transduction and CD19-mediated homotypic adhesion in B cell lines derived from Burkitt's lymphoma. |
| TextSentencer_T3 | 338-621 | Sentence | denotes | These roles for Gb3 may involve the proteins IFNAR-1 (subunit 1 of the interferon-alpha receptor) and CD19, respectively, both of which have potential Gb3-binding sites in their extracellular domains which resemble those of the verotoxin (Shiga toxin and Shiga-like toxin) B subunit. |
| TextSentencer_T4 | 622-742 | Sentence | denotes | The majority of this work was performed using wild-type Daudi cells and a single, Gb3-deficient mutant cell line, VT500. |
| TextSentencer_T5 | 743-962 | Sentence | denotes | In the present investigations, these and additional Daudi-derived cells with varying degrees of sensitivity to interferon-alpha were examined for Gb3 expression, interferon-induced growth inhibition and CD19 expression. |
| TextSentencer_T6 | 963-1098 | Sentence | denotes | The degree of interferon-induced growth inhibition and CD19 expression correlated with Gb3 expression in the various cell lines tested. |
| TextSentencer_T7 | 1099-1262 | Sentence | denotes | In addition, reconstitution of the VT500 cell line with Gb3 but not other glycolipids partially restored the sensitivity of cells to IFN-induced growth inhibition. |
| TextSentencer_T8 | 1263-1470 | Sentence | denotes | The degree to which reconstitution restored sensitivity to growth inhibition was similar to the results of previous studies in which Gb3 reconstitution restored sensitivity to verotoxin-induced cytotoxicity. |
| TextSentencer_T9 | 1471-1674 | Sentence | denotes | These results demonstrate that Gb3 is specifically required for IFN-induced growth inhibition in Daudi cells and provide further evidence of a role for Gb3 in CD19 expression and function in these cells. |
| T1 | 0-124 | Sentence | denotes | Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells. |
| T2 | 125-337 | Sentence | denotes | Previous studies have indicated that globotriaosyl ceramide (Gb3 or CD77) plays a role in alpha-interferon signal transduction and CD19-mediated homotypic adhesion in B cell lines derived from Burkitt's lymphoma. |
| T3 | 338-621 | Sentence | denotes | These roles for Gb3 may involve the proteins IFNAR-1 (subunit 1 of the interferon-alpha receptor) and CD19, respectively, both of which have potential Gb3-binding sites in their extracellular domains which resemble those of the verotoxin (Shiga toxin and Shiga-like toxin) B subunit. |
| T4 | 622-742 | Sentence | denotes | The majority of this work was performed using wild-type Daudi cells and a single, Gb3-deficient mutant cell line, VT500. |
| T5 | 743-962 | Sentence | denotes | In the present investigations, these and additional Daudi-derived cells with varying degrees of sensitivity to interferon-alpha were examined for Gb3 expression, interferon-induced growth inhibition and CD19 expression. |
| T6 | 963-1098 | Sentence | denotes | The degree of interferon-induced growth inhibition and CD19 expression correlated with Gb3 expression in the various cell lines tested. |
| T7 | 1099-1262 | Sentence | denotes | In addition, reconstitution of the VT500 cell line with Gb3 but not other glycolipids partially restored the sensitivity of cells to IFN-induced growth inhibition. |
| T8 | 1263-1470 | Sentence | denotes | The degree to which reconstitution restored sensitivity to growth inhibition was similar to the results of previous studies in which Gb3 reconstitution restored sensitivity to verotoxin-induced cytotoxicity. |
| T9 | 1471-1674 | Sentence | denotes | These results demonstrate that Gb3 is specifically required for IFN-induced growth inhibition in Daudi cells and provide further evidence of a role for Gb3 in CD19 expression and function in these cells. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-22 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Globotriaosyl ceramide |
| T2 | 162-184 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | globotriaosyl ceramide |
| T3 | 186-189 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
| T4 | 354-357 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
| T5 | 489-492 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
| T6 | 704-707 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
| T7 | 889-892 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
| T8 | 1050-1053 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
| T9 | 1155-1158 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
| T10 | 1396-1399 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
| T11 | 1502-1505 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
| T12 | 1623-1626 | https://glytoucan.org/Structures/Glycans/G00059MO | denotes | Gb3 |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 186-189 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
| T2 | 354-357 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
| T3 | 489-492 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
| T4 | 704-707 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
| T5 | 889-892 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
| T6 | 1050-1053 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
| T7 | 1155-1158 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
| T8 | 1396-1399 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
| T9 | 1502-1505 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
| T10 | 1623-1626 | http://www.glycoepitope.jp/epitopes/EP0071 | denotes | Gb3 |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 80-84 | gene:930 | denotes | CD19 |
| T1 | 109-117 | disease:C0024299 | denotes | lymphoma |
| T2 | 256-260 | gene:930 | denotes | CD19 |
| T3 | 328-336 | disease:C0024299 | denotes | lymphoma |
| R1 | T0 | T1 | associated_with | CD19,lymphoma |
| R2 | T2 | T3 | associated_with | CD19,lymphoma |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 99-117 | Phenotype | denotes | Burkitt's lymphoma | HP:0030080 |
| T2 | 318-336 | Phenotype | denotes | Burkitt's lymphoma | HP:0030080 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 99-117 | Disease | denotes | Burkitt's lymphoma | http://purl.obolibrary.org/obo/MONDO_0007243 |
| T2 | 318-336 | Disease | denotes | Burkitt's lymphoma | http://purl.obolibrary.org/obo/MONDO_0007243 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 186-189 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T2 | 354-357 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T3 | 489-492 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T4 | 704-707 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T5 | 889-892 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T6 | 1050-1053 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T7 | 1155-1158 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T8 | 1396-1399 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T9 | 1502-1505 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T10 | 1623-1626 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
GlyCosmos-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 186-189 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T2 | 354-357 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T3 | 489-492 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T4 | 704-707 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T5 | 889-892 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T6 | 1050-1053 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T7 | 1155-1158 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T8 | 1396-1399 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T9 | 1502-1505 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T10 | 1623-1626 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 99-117 | Phenotype | denotes | Burkitt's lymphoma | HP:0030080 |
| T2 | 318-336 | Phenotype | denotes | Burkitt's lymphoma | HP:0030080 |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 99-117 | Disease | denotes | Burkitt's lymphoma | http://purl.obolibrary.org/obo/MONDO_0007243 |
| T2 | 318-336 | Disease | denotes | Burkitt's lymphoma | http://purl.obolibrary.org/obo/MONDO_0007243 |
GlyCosmos15-CL
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 292-298 | Cell | denotes | B cell | http://purl.obolibrary.org/obo/CL:0000236 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 292-298 | Body_part | denotes | B cell | http://purl.obolibrary.org/obo/CL_0000236 |
| T2 | 516-529 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-124 | Sentence | denotes | Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells. |
| TextSentencer_T2 | 125-337 | Sentence | denotes | Previous studies have indicated that globotriaosyl ceramide (Gb3 or CD77) plays a role in alpha-interferon signal transduction and CD19-mediated homotypic adhesion in B cell lines derived from Burkitt's lymphoma. |
| TextSentencer_T3 | 338-621 | Sentence | denotes | These roles for Gb3 may involve the proteins IFNAR-1 (subunit 1 of the interferon-alpha receptor) and CD19, respectively, both of which have potential Gb3-binding sites in their extracellular domains which resemble those of the verotoxin (Shiga toxin and Shiga-like toxin) B subunit. |
| TextSentencer_T4 | 622-742 | Sentence | denotes | The majority of this work was performed using wild-type Daudi cells and a single, Gb3-deficient mutant cell line, VT500. |
| TextSentencer_T5 | 743-962 | Sentence | denotes | In the present investigations, these and additional Daudi-derived cells with varying degrees of sensitivity to interferon-alpha were examined for Gb3 expression, interferon-induced growth inhibition and CD19 expression. |
| TextSentencer_T6 | 963-1098 | Sentence | denotes | The degree of interferon-induced growth inhibition and CD19 expression correlated with Gb3 expression in the various cell lines tested. |
| TextSentencer_T7 | 1099-1262 | Sentence | denotes | In addition, reconstitution of the VT500 cell line with Gb3 but not other glycolipids partially restored the sensitivity of cells to IFN-induced growth inhibition. |
| TextSentencer_T8 | 1263-1470 | Sentence | denotes | The degree to which reconstitution restored sensitivity to growth inhibition was similar to the results of previous studies in which Gb3 reconstitution restored sensitivity to verotoxin-induced cytotoxicity. |
| TextSentencer_T9 | 1471-1674 | Sentence | denotes | These results demonstrate that Gb3 is specifically required for IFN-induced growth inhibition in Daudi cells and provide further evidence of a role for Gb3 in CD19 expression and function in these cells. |
| T1 | 0-124 | Sentence | denotes | Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells. |
| T2 | 125-337 | Sentence | denotes | Previous studies have indicated that globotriaosyl ceramide (Gb3 or CD77) plays a role in alpha-interferon signal transduction and CD19-mediated homotypic adhesion in B cell lines derived from Burkitt's lymphoma. |
| T3 | 338-621 | Sentence | denotes | These roles for Gb3 may involve the proteins IFNAR-1 (subunit 1 of the interferon-alpha receptor) and CD19, respectively, both of which have potential Gb3-binding sites in their extracellular domains which resemble those of the verotoxin (Shiga toxin and Shiga-like toxin) B subunit. |
| T4 | 622-742 | Sentence | denotes | The majority of this work was performed using wild-type Daudi cells and a single, Gb3-deficient mutant cell line, VT500. |
| T5 | 743-962 | Sentence | denotes | In the present investigations, these and additional Daudi-derived cells with varying degrees of sensitivity to interferon-alpha were examined for Gb3 expression, interferon-induced growth inhibition and CD19 expression. |
| T6 | 963-1098 | Sentence | denotes | The degree of interferon-induced growth inhibition and CD19 expression correlated with Gb3 expression in the various cell lines tested. |
| T7 | 1099-1262 | Sentence | denotes | In addition, reconstitution of the VT500 cell line with Gb3 but not other glycolipids partially restored the sensitivity of cells to IFN-induced growth inhibition. |
| T8 | 1263-1470 | Sentence | denotes | The degree to which reconstitution restored sensitivity to growth inhibition was similar to the results of previous studies in which Gb3 reconstitution restored sensitivity to verotoxin-induced cytotoxicity. |
| T9 | 1471-1674 | Sentence | denotes | These results demonstrate that Gb3 is specifically required for IFN-induced growth inhibition in Daudi cells and provide further evidence of a role for Gb3 in CD19 expression and function in these cells. |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-124 | Sentence | denotes | Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells. |
| T2 | 125-337 | Sentence | denotes | Previous studies have indicated that globotriaosyl ceramide (Gb3 or CD77) plays a role in alpha-interferon signal transduction and CD19-mediated homotypic adhesion in B cell lines derived from Burkitt's lymphoma. |
| T3 | 338-621 | Sentence | denotes | These roles for Gb3 may involve the proteins IFNAR-1 (subunit 1 of the interferon-alpha receptor) and CD19, respectively, both of which have potential Gb3-binding sites in their extracellular domains which resemble those of the verotoxin (Shiga toxin and Shiga-like toxin) B subunit. |
| T4 | 622-742 | Sentence | denotes | The majority of this work was performed using wild-type Daudi cells and a single, Gb3-deficient mutant cell line, VT500. |
| T5 | 743-962 | Sentence | denotes | In the present investigations, these and additional Daudi-derived cells with varying degrees of sensitivity to interferon-alpha were examined for Gb3 expression, interferon-induced growth inhibition and CD19 expression. |
| T6 | 963-1098 | Sentence | denotes | The degree of interferon-induced growth inhibition and CD19 expression correlated with Gb3 expression in the various cell lines tested. |
| T7 | 1099-1262 | Sentence | denotes | In addition, reconstitution of the VT500 cell line with Gb3 but not other glycolipids partially restored the sensitivity of cells to IFN-induced growth inhibition. |
| T8 | 1263-1470 | Sentence | denotes | The degree to which reconstitution restored sensitivity to growth inhibition was similar to the results of previous studies in which Gb3 reconstitution restored sensitivity to verotoxin-induced cytotoxicity. |
| T9 | 1471-1674 | Sentence | denotes | These results demonstrate that Gb3 is specifically required for IFN-induced growth inhibition in Daudi cells and provide further evidence of a role for Gb3 in CD19 expression and function in these cells. |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 186-189 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T2 | 354-357 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T3 | 489-492 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T4 | 704-707 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T5 | 889-892 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T6 | 1050-1053 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T7 | 1155-1158 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T8 | 1396-1399 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T9 | 1502-1505 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
| T10 | 1623-1626 | Glycan | denotes | Gb3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00059MO |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 186-189 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T2 | 354-357 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T3 | 489-492 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T4 | 704-707 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T5 | 889-892 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T6 | 1050-1053 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T7 | 1155-1158 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T8 | 1396-1399 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T9 | 1502-1505 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
| T10 | 1623-1626 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Gb3 | http://www.glycoepitope.jp/epitopes/EP0071 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 292-298 | Body_part | denotes | B cell | http://purl.obolibrary.org/obo/CL_0000236 |
| T2 | 516-529 | Body_part | denotes | extracellular | http://purl.obolibrary.org/obo/GO_0005576 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 292-298 | Cell | denotes | B cell | http://purl.obolibrary.org/obo/CL:0000236 |